1,219
Views
10
CrossRef citations to date
0
Altmetric
Prostate cancer

Establishing implantation uncertainties for focal brachytherapy with I-125 seeds for the treatment of localized prostate cancer

, , , , , , & show all
Pages 839-846 | Received 10 Jun 2014, Accepted 01 Dec 2014, Published online: 16 Jan 2015

References

  • Mohammed N, Kestin L, Ghilezan M, Krauss D, Vicini F, Brabbins D, et al. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer. Int J Radiat Oncol 2012;82: 204–12.
  • Ahmed HU, Arya M, Freeman A, Emberton M. Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? Lancet Oncol 2012;13:e509–17.
  • De la Rosette J, Ahmed H, Barentsz J, Johansen TB, Brausi M, Emberton M, et al. Focal therapy in prostate cancer—report from a consensus panel. J Endourol 2010;24:775–80.
  • Eggener S, Salomon G, Scardino PT, De la Rosette J, Polascik TJ, Brewster S. Focal therapy for prostate cancer: Possibilities and limitations. Eur Urol 2010;58:57–64.
  • Langley S, Ahmed HU, Al-Qaisieh B, Bostwick D, Dickinson L, Veiga FG, et al. Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer. Br J Urol Int 2012;109:7–16.
  • Roberson PL, Narayana V, McShan DL, Winfield RJ, McLaughlin PW. Source placement error for permanent implant of the prostate. Med Phys 1997;24:251–7.
  • Lobo JR, Moradi M, Chng N, Dehghan E, Morris WJ, Fichtinger G, et al. Use of needle track detection to quantify the displacement of stranded seeds following prostate brachytherapy. IEEE Trans Med Imaging 2012;31:738–48.
  • Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 1999;10:223–32
  • Van der Heide UA, Houweling AC, Groenendaal G, Beets-Tan RGH, Lambin P. Functional MRI for radiotherapy dose painting. Magn Reson Imaging 2012;30:1216–23.
  • Salembier C, Lavagnini P, Nickers P, Mangili P, Rijnders A, Polo A, et al. Tumour and target volumes in permanent prostate brachytherapy: A supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. Radiother Oncol 2007;83:3–10.
  • Steggerda MJ1, Witteveen T, van den Boom F, Moonen LM. Is there a relation between the radiation dose to the different sub-segments of the lower urinary tract and urinary morbidity after brachytherapy of the prostate with I-125 seeds? Radiother Oncol 2013;109:251–5.
  • Rao M, Stough J, Chi Y-Y, Muller K, Tracton G, Pizer SM, et al. Comparison of human and automatic segmentations of kidneys from CT images. Int J Radiat Oncol Biol Phys 2005;61:954–60.
  • Steggerda MJ, van der Poel HG, Moonen LMF. Minimizing the number of implantation needles for prostate 125I brachytherapy: An investigation of possibilities and implications. Brachytherapy 2010;9:319–27.
  • Moerland MA, van Deursen MJH, Elias SG, van Vulpen M, Jürgenliemk-Schulz IM, Battermann JJ. Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: Comparison between loose and stranded seed implants. Radiother Oncol 2009;91:202–6.
  • Polo A, Salembier C, Venselaar J, Hoskin P. Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy. Radiother Oncol 2010;94:12–23.
  • Su Y, Davis BJ, Furutani KM, Herman MG, Robb RA. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: Increased seed number correlates with less variability in prostate dosimetry. Phys Med Biol 2007;52:3105–19.
  • Kirisits C, Rivard MJ, Baltas D, Ballester F, De Brabandere M, van der Laarse R, et al. Review of clinical brachytherapy uncertainties: Analysis guidelines of GEC-ESTRO and the AAPM. Radiother Oncol 2014;110:199–212.
  • De Brabandere M, Hoskin P, Haustermans K, Van den Heuvel F, Siebert FA. Prostate post-implant dosimetry: Interobserver variability in seed localisation, contouring and fusion. Radiother Oncol 2012;104:192–8.
  • Bratan F, Niaf E, Melodelima C, Chesnais AL, Souchon R, Mège-Lechevallier F, et al. Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: A prospective study. Eur Radiol 2013;23:2019–29.
  • Rischke HC, Nestle U, Fechter T, Doll C, Volegova-Neher N, Henne K, et al. 3 Tesla multiparametric MRI for GTV- definition of dominant intraprostatic lesions in patients with prostate cancer–an interobserver variability study. Radiat Oncol 2013;8:183.
  • De Brabandere M, Kirisits C, Peeters R, Haustermans K, Van den Heuvel F. Accuracy of seed reconstruction in prostate postplanning studied with a CT- and MRI-compatible phantom. Radiother Oncol 2006;79:190–7.
  • Siebert FA, De Brabandere M, Kirisits C, Kovács G, Venselaar J. Phantom investigations on CT seed imaging for interstitial brachytherapy. Radiother Oncol 2007;85:316–23
  • Mason J, Al-Qaisieh B, Bownes P, Wilson D, Buckley DL, Thwaites D, et al. Multi-parametric MRI-guided focal tumor boost using HDR prostate brachytherapy: A feasibility study. Brachytherapy 2014;13:137–45.
  • Taschereau R, Pouliot J, Roy J, Tremblay D. Seed mis- placement and stabilizing needles in transperineal permanent prostate implants. Radiother Oncol 2000;55: 59–63.
  • Cosset J-M, Cathelineau X, Wakil G, Pierrat N, Quenzer O, Prapotnich D et al. Focal brachytherapy for selected low-risk prostate cancers: A pilot study. Brachytherapy 2013;12: 331–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.